A clinical trial to study the effect of the drug karappan nei in patients having Bala karappan( Atopic Dermatitis)

Phase II an open single group non randomised study on Bala karappan (Atopic Dermatitis) to evaluate the official siddha formulation karappan nei(Int &Ext) in children of both sex aging between 3-12 years attending OPD at Anna hospital

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/11/022161

Enrollment

Registered

2019-11-27

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L209- Atopic dermatitis, unspecified

Interventions

Intervention1: Karappan nei: 5- 10 ml of karappan nei is given twice day for 21 days Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: Severe itching Erythema Vesicles Oozing Lichenification

Exclusion criteria

Exclusion criteria: Scabies Photo dermatitis Secondary bacterial infection Furunculosis Psoriasis

Design outcomes

Primary

Measure	Time frame
Reduction in EASI score(Eczema Area Severity Index) Reduction in clinical symptoms like itching oozing lichenification Photos of the patient before and after treatment for the evidence of clinical improvementTimepoint: 21 days	—

Secondary

Measure	Time frame
It is assessed by comparing the safety parameters before and after treatmentTimepoint: 21 days	—

Countries

India

Contacts

Public ContactDrSri sathyaG

Government siddha medical college

ranimoorthybsms19@gmail.com9442286863

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026